183 related articles for article (PubMed ID: 17924606)
1. Learning how and when to employ uricase as bridge therapy in refractory gout.
Terkeltaub R
J Rheumatol; 2007 Oct; 34(10):1955-8. PubMed ID: 17924606
[No Abstract] [Full Text] [Related]
2. Uricase and other novel agents for the management of patients with treatment-failure gout.
Sundy JS; Hershfield MS
Curr Rheumatol Rep; 2007 Jun; 9(3):258-64. PubMed ID: 17531181
[TBL] [Abstract][Full Text] [Related]
3. Pegloticase, a polyethylene glycol conjugate of uricase for the potential intravenous treatment of gout.
Biggers K; Scheinfeld N
Curr Opin Investig Drugs; 2008 Apr; 9(4):422-9. PubMed ID: 18393109
[TBL] [Abstract][Full Text] [Related]
4. Urate oxidase (rasburicase) for treatment of severe tophaceous gout.
Vogt B
Nephrol Dial Transplant; 2005 Feb; 20(2):431-3. PubMed ID: 15673692
[No Abstract] [Full Text] [Related]
5. Rasburicase treatment in severe tophaceous gout: a novel therapeutic option.
Moolenburgh JD; Reinders MK; Jansen TL
Clin Rheumatol; 2006 Sep; 25(5):749-52. PubMed ID: 16247589
[TBL] [Abstract][Full Text] [Related]
6. [Gout: an overview of available urate lowering therapies].
Richette P
Ann Pharm Fr; 2012 May; 70(3):133-8. PubMed ID: 22655581
[TBL] [Abstract][Full Text] [Related]
7. Pegloticase for treating refractory chronic gout.
George RL; Sundy JS
Drugs Today (Barc); 2012 Jul; 48(7):441-9. PubMed ID: 22844655
[TBL] [Abstract][Full Text] [Related]
8. Resolution of massive tophaceous gout with three urate-lowering drugs.
Mejía-Chew C; Torres RJ; de Miguel E; Puig JG
Am J Med; 2013 Nov; 126(11):e9-10. PubMed ID: 23978312
[No Abstract] [Full Text] [Related]
9. Enhancing the Response Rate to Recombinant Uricases in Patients with Gout.
Schlesinger N; Padnick-Silver L; LaMoreaux B
BioDrugs; 2022 Mar; 36(2):95-103. PubMed ID: 35316517
[TBL] [Abstract][Full Text] [Related]
10. Reversal of chronic refractory tophaceous gout with erosions with pegloticase.
Yeter KC; Ortiz EC; Arkfeld DG
Int J Rheum Dis; 2013 Jun; 16(3):369-70. PubMed ID: 23981765
[No Abstract] [Full Text] [Related]
11. Debulking the urate load to feel better.
Richette P
J Rheumatol; 2012 Jul; 39(7):1311-3. PubMed ID: 22753797
[No Abstract] [Full Text] [Related]
12. Alternative treatment for chronic gout could relieve pain for thousands. The recently approved intravenous drug, pegloticase, may work when other treatments don't.
Duke Med Health News; 2013 Jan; 19(1):3. PubMed ID: 23762971
[No Abstract] [Full Text] [Related]
13. Update on emerging urate-lowering therapies.
Chohan S; Becker MA
Curr Opin Rheumatol; 2009 Mar; 21(2):143-9. PubMed ID: 19339925
[TBL] [Abstract][Full Text] [Related]
14. Pegloticase and the patient with treatment-failure gout.
Dave AJ; Kelly VM; Krishnan E
Expert Rev Clin Pharmacol; 2012 Sep; 5(5):501-8. PubMed ID: 23121270
[TBL] [Abstract][Full Text] [Related]
15. Crystal arthritis. Intensive urate-lowering therapy improves structural joint damage in patients with tophaceous gout.
Buckland J
Nat Rev Rheumatol; 2013 Sep; 9(9):506. PubMed ID: 23897441
[No Abstract] [Full Text] [Related]
16. Treatment-failure gout: a moving target.
Edwards NL
Arthritis Rheum; 2008 Sep; 58(9):2587-90. PubMed ID: 18759307
[No Abstract] [Full Text] [Related]
17. Treatment failure gout.
Ali S; Lally EV
Med Health R I; 2009 Nov; 92(11):369-71. PubMed ID: 19999896
[No Abstract] [Full Text] [Related]
18. A challenging case of gout and failure of anti-TNF therapy- are current treatments adequate?
Nisar MK; Baburaj K
Int J Rheum Dis; 2011 Aug; 14(3):e42-3. PubMed ID: 21816013
[No Abstract] [Full Text] [Related]
19. [Rasburicase for tophaceus gout treatment].
Ribeiro A; Bogas M; Costa J; Costa L; Araújo D
Acta Reumatol Port; 2009; 34(3):551-4. PubMed ID: 19820680
[TBL] [Abstract][Full Text] [Related]
20. Gout: a comprehensive review.
Rymal E; Rizzolo D
JAAPA; 2014 Sep; 27(9):26-31. PubMed ID: 25102078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
